Boston Scientific (BSX) EBT (QoQ) (2009 - 2026)
Analysis
Boston Scientific (BSX) EBT (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.84 Bn | 178.24 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.30 Bn | 119.09 Bn | 1.96 Bn |
| 3 | Medtronic | 118.47 Bn | 109.65 Bn | 6.34 Bn |
| 4 | Stryker | 106.24 Bn | 102.77 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.67 Bn | 66.13 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.69 Bn | 45.43 Bn | 1.35 Bn |
| 7 | Alcon | 34.03 Bn | 32.57 Bn | 1.68 Bn |
| 8 | Dexcom | 32.09 Bn | 30.14 Bn | 830.00 Mn |
| 9 | Steris | 21.14 Bn | 20.66 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.27 Bn | 17.86 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.78% |
| Mar 31, 2026 | 66.00% |
| Dec 31, 2025 | -25.45% |
| Sep 30, 2025 | -0.21% |
| Jun 30, 2025 | 16.89% |
| Mar 31, 2025 | 37.61% |
| Dec 31, 2024 | -12.56% |
| Sep 30, 2024 | 59.29% |
| Jun 30, 2024 | -30.92% |
| Mar 31, 2024 | 20.40% |
| Dec 31, 2023 | -17.21% |
| Sep 30, 2023 | 43.19% |
| Jun 30, 2023 | -4.05% |
| Mar 31, 2023 | 12.12% |
| Dec 31, 2022 | 61.63% |
| Sep 30, 2022 | -28.99% |
| Jun 30, 2022 | 121.15% |
| Mar 31, 2022 | 31.09% |
| Dec 31, 2021 | -75.36% |
| Sep 30, 2021 | 224.16% |